Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Patients may need more frequent blood sugar checks and should watch for symptoms of hyperglycemia (high blood sugar)
Inject slowly into a muscle or vein
Nadia Ahmad, an associate vice president at Eli Lilly and medical director of obesity clinical development for the company
.png)
FDA approval of Zepbound was based on results from the phase 3 SURMOUNT-1 (adults with obesity or overweight and without type 2 diabetes) and SURMOUNT-2 (adults with obesity or overweight and with type 2 diabetes) trials which both demonstrated a statistically significant reduction in body weight compared to those who received placebo after 72 weeks of treatment
US$ 26.92
US$ 22.94
US$ 26.73
US$ 24.13
US$ 28.58
US$ 26.71
US$ 27.17
US$ 29.11
